Literature DB >> 16316833

[Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer].

Valérie Hammerer1, Gabrielle Pauli, Elisabeth Quoix.   

Abstract

Carcinomatous meningitis occur in approximately 5 to 18% of bronchial carcinoma. We report here the analysis of a retrospective study of 26 cases of carcinomatous meningitis secondary to a bronchial carcinoma. The most frequently involved histological types are adenocarcinoma and small cell lung cancer. The diagnosis is difficult because of the clinical polymorphism and the inconstant presence of neoplasic cells in the cerebrospinal fluid. The prognosis is very poor with a median survival time of 4 weeks. Development of new molecules as well as an earlier diagnosis could contribute to improve the outcome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316833

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  5 in total

1.  Unusual recurrence of small cell lung carcinoma.

Authors:  Mohammad Alkhalil; Mohamed Ali Eid; Aatif Mahmood; Marta Babores
Journal:  BMJ Case Rep       Date:  2010-02-25

2.  Ovarian small cell carcinoma complicated by carcinomatous meningitis.

Authors:  Naoko Kira; Noriyuki Takai; Terukazu Ishii; Kentaro Kai; Masakazu Nishida; Kaei Nasu; Kenji Kashima; Hisashi Narahara
Journal:  Rare Tumors       Date:  2012-05-17

3.  Clinical Improvement and Prolonged Survival With High Dose Intrathecal Methotrexate for Carcinomatous Meningitis Secondary to a Lung Adenocarcinoma.

Authors:  Florian Clatot; Philippe David; Sophie Laberge-Le-Couteulx; Emmanuel Blot
Journal:  World J Oncol       Date:  2011-10-28

4.  Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Authors:  Emilie Le Rhun; Sophie Taillibert; Marc C Chamberlain
Journal:  Surg Neurol Int       Date:  2013-05-02

5.  Carcinomatous myelitis and meningitis after a squamous cell carcinoma of the lip.

Authors:  Isabelle Pougnet; Anne Murati; Anthony Sarran; Patrice Viens; Renaud Sabatier
Journal:  Case Rep Oncol       Date:  2014-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.